BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 26964399)

  • 21. Thiomers: a new generation of mucoadhesive polymers.
    Bernkop-Schnürch A
    Adv Drug Deliv Rev; 2005 Nov; 57(11):1569-82. PubMed ID: 16176846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin.
    Hombach J; Palmberger TF; Bernkop-Schnürch A
    J Pharm Sci; 2009 Feb; 98(2):555-64. PubMed ID: 18563796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations.
    Almeida H; Amaral MH; Lobão P; Lobo JM
    Drug Discov Today; 2014 Apr; 19(4):400-12. PubMed ID: 24120893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan Nanoparticles as a Mucoadhesive Drug Delivery System for Ocular Administration.
    Silva MM; Calado R; Marto J; Bettencourt A; Almeida AJ; Gonçalves LMD
    Mar Drugs; 2017 Dec; 15(12):. PubMed ID: 29194378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery.
    Al Khateb K; Ozhmukhametova EK; Mussin MN; Seilkhanov SK; Rakhypbekov TK; Lau WM; Khutoryanskiy VV
    Int J Pharm; 2016 Apr; 502(1-2):70-9. PubMed ID: 26899977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physico-chemical, in vitro and in vivo characterisation of polymers for ocular use.
    Hartmann V; Keipert S
    Pharmazie; 2000 Jun; 55(6):440-3. PubMed ID: 10907252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of nanosized cross-linked sodium-, linear sodium- and zinc-hyaluronate as potential ocular mucoadhesive drug delivery systems.
    Horvát G; Budai-Szűcs M; Berkó S; Szabó-Révész P; Soós J; Facskó A; Maroda M; Mori M; Sandri G; Bonferoni MC; Caramella C; Csányi E
    Int J Pharm; 2015 Oct; 494(1):321-8. PubMed ID: 26319587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal drug delivery: Design of a novel mucoadhesive and in situ gelling polymer.
    Menzel C; Jelkmann M; Laffleur F; Bernkop-Schnürch A
    Int J Pharm; 2017 Jan; 517(1-2):196-202. PubMed ID: 27890621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucoadhesive self-emulsifying delivery systems for ocular administration of econazole.
    Elbahwy IA; Lupo N; Ibrahim HM; Ismael HR; Kasem AA; Caliskan C; Matuszczak B; Bernkop-Schnürch A
    Int J Pharm; 2018 Apr; 541(1-2):72-80. PubMed ID: 29458206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiolated polymers--thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates.
    Kast CE; Bernkop-Schnürch A
    Biomaterials; 2001 Sep; 22(17):2345-52. PubMed ID: 11511031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems.
    Takeuchi H; Thongborisute J; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
    Adv Drug Deliv Rev; 2005 Nov; 57(11):1583-94. PubMed ID: 16169120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiomers: potential excipients for non-invasive peptide delivery systems.
    Bernkop-Schnürch A; Krauland AH; Leitner VM; Palmberger T
    Eur J Pharm Biopharm; 2004 Sep; 58(2):253-63. PubMed ID: 15296953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
    Al-Kassas RS; El-Khatib MM
    Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New method for ophthalmic delivery of azithromycin by poloxamer/carbopol-based in situ gelling system.
    Cao F; Zhang X; Ping Q
    Drug Deliv; 2010; 17(7):500-7. PubMed ID: 20500130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can thiolation render a low molecular weight polymer of just 20-kDa mucoadhesive?
    Mahmood A; Bonengel S; Laffleur F; Ijaz M; Idrees MA; Hussain S; Huck CW; Matuszczak B; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2016; 42(5):686-93. PubMed ID: 26133081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temperature-responsive, Pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property.
    Ma WD; Xu H; Nie SF; Pan WS
    Drug Dev Ind Pharm; 2008 Mar; 34(3):258-66. PubMed ID: 18363141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetradeca-thiolated cyclodextrins: Highly mucoadhesive and in-situ gelling oligomers with prolonged mucosal adhesion.
    Hussain Asim M; Nazir I; Jalil A; Matuszczak B; Bernkop-Schnürch A
    Int J Pharm; 2020 Mar; 577():119040. PubMed ID: 31953091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery.
    Shen J; Wang Y; Ping Q; Xiao Y; Huang X
    J Control Release; 2009 Aug; 137(3):217-23. PubMed ID: 19393270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ophthalmic delivery systems based on drug-polymer-polymer ionic ternary interaction: in vitro and in vivo characterization.
    Sandri G; Bonferoni MC; Chetoni P; Rossi S; Ferrari F; Ronchi C; Caramella C
    Eur J Pharm Biopharm; 2006 Jan; 62(1):59-69. PubMed ID: 16162402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.